Congenital hypothyroidism in Calabria: epidemiological and clinical aspects

Mariangiola Baserga1, Maria Novella Pullano

  • 1Centro Regionale di Diagnosi e Follow-up dell' Ipotiroidismo Congenito, Cattedra di Pediatria, Università degli Studi Magna Graecia, Ospedale Pugliese, Catanzaro, Italy. mbaserga@unicz.it

Insights

Neonatal screening for congenital hypothyroidism (CH) is crucial for preventing brain damage. Lowering the TSH cut-off in Calabria increased CH diagnoses, including transitional forms.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neonatal Screening

Background:

  • Congenital hypothyroidism (CH) is a leading cause of preventable brain damage in newborns.
  • Neonatal screening for CH is vital, typically performed on days 3-5 of life.
  • Recent changes in TSH cut-off values have impacted CH diagnosis rates.

Purpose of the Study:

  • To analyze the impact of a lowered TSH cut-off on CH diagnosis in Calabria.
  • To investigate the characteristics of newly diagnosed CH cases, including thyroid status and form.

Main Methods:

  • Retrospective analysis of neonatal screening data in Calabria.
  • Utilized TSH levels from blood spot tests.
  • Correlated TSH values with ultrasound findings and clinical diagnosis.

Main Results:

  • A lowered TSH cut-off significantly increased the frequency of CH diagnoses.
  • A notable proportion of new cases presented with normal in situ thyroid ultrasound.
  • Transitional forms of CH were increasingly diagnosed.

Conclusions:

  • The revised TSH cut-off effectively identifies more CH cases, including milder forms.
  • Continued monitoring and research are necessary to understand the long-term implications of these findings.
  • Optimized screening protocols are essential for early intervention and improved outcomes in congenital hypothyroidism.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...